Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
750.00
-19.85 (-2.58%)
Nov 12, 2026, 3:30 PM IST
NSE:AKUMS Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, NSE:AKUMS stock has a consensus rating of "Strong Buy" and an average price target of ₹915.00. The average 1-year stock price forecast is 22.00% higher than the current stock price, while the lowest is ₹860.00 (+14.67%) and the highest is ₹960.00 (+28.00%).
Price Target: ₹915.00 (+22.00%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:AKUMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
52.54B
from 43.61B
Increased by 20.46%
Revenue Next Year
60.50B
from 52.54B
Increased by 15.15%
EPS This Year
28.60
from 17.55
Increased by 62.98%
EPS Next Year
35.63
from 28.60
Increased by 24.58%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.